Takeda Ventures

Investor type

CVC

Founded

1781

AUM

-

Location

United States

Investment Ticket

$0-1 m

Investment Stage

Seed Series A

Region of investment

North America Europe Asia

ESG Focus

Impact investor
Investor profile last updated: 17 November, 2021

Profile

Takeda's journey expands and advances the translation of science into highly innovative medicines while maintaining our agility as a global, values-based, R&D-driven, biopharmaceutical leader.

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 240 years of distinguished history in Japan.

We aspire to be a dynamic R&D organization that thinks, acts and interacts with the external world like no other. Our global team of researchers and scientists achieve this by harnessing cutting-edge science to push the boundaries of what is possible in order to bring transformative, life-changing therapies to patients worldwide. Hear some voices from our global R&D team and find out more about our therapeutic areas here.

Industry

Healthcare Services Software HealthTech Medical Devices Pharmaceuticals

Contacts

Name
Title
Email
avatar
Andrew S. Plump, M.D., Ph.D. Director President, Research & Development
Director President, Research & Development
-
avatar
Ramona Sequeira President, U.S. Business Unit and Global Portfolio Commercialization
President, U.S. Business Unit and Global Portfolio Commercialization
-
Upgrade to see contacts
avatar
J58F7TkYsfXuc340 J58F7TkYsfXuc340
J58F7TkYsfXuc340
avatar
J58F7TkYsfXuc340 J58F7TkYsfXuc340
J58F7TkYsfXuc340
avatar
J58F7TkYsfXuc340 J58F7TkYsfXuc340
J58F7TkYsfXuc340
Investment-team contacts for Takeda Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Takeda Ventures

Takeda Ventures operates as a corporate VC (CVC). It backs companies at Seed and Series A, writing tickets of $0-1 m.
Takeda Ventures is located in United States.
Takeda Ventures was founded in 1781.
Takeda Ventures invests in companies and startups in Healthcare Services, Software, HealthTech, Medical Devices, Pharmaceuticals.
Takeda Ventures invests in companies and startups in North America, Europe, Asia.
Takeda Ventures invests in companies and startups at Seed, Series A.
Takeda Ventures usually invests $0-1 m on average.
Yes, Takeda Ventures is impact investor.
Takeda Ventures can be reached through its website takedaventures.com, its LinkedIn page and its X account. Its general enquiries address is -. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Takeda Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Takeda Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 17 November, 2021. Something out of date here? Report it — we re-run that firm within 48h and get back to you.